Hanna Svanbäck

Hanna Svanbäck is currently the Business Unit Director for Neuroscience at Eli Lilly and Company, a position held since 2023. Previously, they served in various roles at Eli Lilly, including Medical Affairs Manager and Medical Director, contributing to leadership and people management across the Northern European hub. Hanna has also worked as a Clinical Research Associate at Quintiles and completed a Master’s thesis in process development at AstraZeneca R&D. They hold a Master of Science degree in Biotechnology from The University of Manchester and an engineering degree from Umeå University.